Waad Alghamdi

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Transcription Factor

Randomized Controlled Trial

Top Venues

International journal of environmental research and public health

Drugs - real world outcomes

This page only lists publications with an associated author ORCID identifier.

Publications

Waad Alghamdi, Nouf Al-Fadel, Eman A Alghamdi, Maha Alghamdi, Fawaz Alharbi
Signal Detection and Assessment of Herb-Drug Interactions: Saudi Food and Drug Authority SFDA Experience. Drugs - real world outcomes (2023)
Waad Alghamdi, Nouf Al-Fadel, Eman A Alghamdi, Maha Alghamdi, Fawaz Alharbi
Author Correction: Signal Detection and Assessment of Herb-Drug Interactions: Saudi Food and Drug Authority Experience. Drugs - real world outcomes (2023)
Ahmad Alharbi, Attiah Khobrani, Afnan Noor, Waad Alghamdi, Abdulmalik Alotaibi, Mohammed A Alnuhait, Abdul Haseeb
Risk of Lichen Sclerosus and Lichen Planus in Patients Receiving Immune Checkpoint Inhibitors. International journal of environmental research and public health 20 (1) (2022)
Ahmad Alharbi, Attiah Khobrani, Afnan Noor, Waad Alghamdi, Abdulmalik Alotaibi, Mohammed A Alnuhait, Abdul Haseeb
Risk of Lichen Sclerosus and Lichen Planus in Patients Receiving Immune Checkpoint Inhibitors. International journal of environmental research and public health 20 (1) (2022)
Ahmad Alharbi, Attiah Khobrani, Afnan Noor, Waad Alghamdi, Abdulmalik Alotaibi, Mohammed A Alnuhait, Abdul Haseeb
Risk of Lichen Sclerosus and Lichen Planus in Patients Receiving Immune Checkpoint Inhibitors. International journal of environmental research and public health 20 (1) (2022)
Ahmad Alharbi, Attiah Khobrani, Afnan Noor, Waad Alghamdi, Abdulmalik Alotaibi, Mohammed A Alnuhait, Abdul Haseeb
Risk of Lichen Sclerosus and Lichen Planus in Patients Receiving Immune Checkpoint Inhibitors. International journal of environmental research and public health 20 (1) (2022)
Ahmad Alharbi, Attiah Khobrani, Afnan Noor, Waad Alghamdi, Abdulmalik Alotaibi, Mohammed A Alnuhait, Abdul Haseeb
Risk of Lichen Sclerosus and Lichen Planus in Patients Receiving Immune Checkpoint Inhibitors. International journal of environmental research and public health 20 (1) (2022)